JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8883 SAR405
33 Citation

Summary: Selective ATP-competitive inhibitor of Vps34

≥22.19 mg/mL
A8701 Mesoridazine Besylate

Summary: Phenothiazine dopamine receptor anatagonist

≥54.58 mg/mL
B4986 LY2409881

Summary: potent and selective IKK2 inhibitor

≥59.4 mg/mL
B5973 PFI 4

Summary: Potent and selective BRPF1 Bromodomain inhibitor

insoluble in H2O; ≥13.3 mg/mL
B6006 NPS-1034

Summary: MET inhibitor

Soluble in DMSO
B6026 VR23

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL
A5467 Ponatinib (AP24534)
1 Citation

Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src

Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor

≥53.3 mg/mL
A5634 SAR245409 (XL765)

Summary: mTOR/PI3K inhibitor

insoluble in H2O; insoluble in EtOH; ≥15 mg/mL
A8321 Cisplatin
36 Citation

Summary: chemotherapeutic compound
A8326 AZD-5438
2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL